NCT04494438View on ClinicalTrials.gov

Rituximab for Idiopathic Nephrotic Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Idiopathic Nephrotic Syndrome
Interventions
DRUG

Rituximab

Trial Locations (1)

16147

IRCCS Giannina Gaslini Institute, Genova

All Listed Sponsors
lead

Istituto Giannina Gaslini

OTHER

NCT04494438 - Rituximab for Idiopathic Nephrotic Syndrome | Biotech Hunter | Biotech Hunter